Disease · MONDO_0044872
Comparisons in its trials16
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 16 of 16
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| HRA Treatment Arm vs Placebo Arm: Proportion of Survey Completion | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Prefer Participating in This Virtual Study | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Felt That the Frequency in Which the Information Was Collected Was Acceptable | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Proportion of Voluntary Termination | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants Satisfied With Their Opportunities to Interact With Study Staff | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Felt That Study Staff Was Available and Easy to Contact to Report Any Adverse Effects | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Proportion of Lost to Follow Up (LFUP) | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Proportion of Study Drug Adherence | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Felt That the Amount of Information Collected in Each Series of Surveys Was Acceptable | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Had Any Confusion Over How to Take the Study Drug, Including Which Pill to Take, When to Take it, or How Many to Take | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Discontinuations or Temporary Suspensions of IP | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Had Trouble Adhering to the Study Drug Schedule | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Felt They Could Reach Study Staff if Needed | 3 of 3 | 2 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: deaths from any cause | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: Number of Participants That Had Any Difficulty Using the REDCap Interface. | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
| HRA Treatment Arm vs Placebo Arm: serious adverse events | 0 of 3 | 0 of 2 | 5 | NCT05946551 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0044872/comparisons